- Expertise
- Services
- Solutions
- About Us
- Resources
- Request Quote



Customized pharmacodynamic biomarkers, cell surface and intracellular antigens, gene expression quantitation, and biomarker analysis CRO services for your therapeutics development!
Development And Validation Of V-PLEX/S-PLEX MSD Assays For High-sensitivity Biomarker Analysis In Plasma, Urine, CSF, And Tissues
Custom U-PLEX MSD Multiplex ELISA Assays For Immune Response And Therapeutic Efficacy Biomarker Measurement In Human Serum
Compound Screening Using MSD Luminex, Alphalisa, And ELISA To Analyze Biomarkers Testing Services In Cell Culture, Plasma, Serum, And CSF
CRISPR/cas9-based MSD Biomarker Assays For Detecting Residual Materials In Genetic Studies And Therapeutic Production
MSD Assay Development, Sample Analysis For Methylated Histones in Monocytes From Human PBMC
Customized Copy Number Multiplex Biomarker Assay on Digital dPCR in DNA Isolates from Human Cell Culture
qRT-PCR Analysis Of RNA From Non-human Primate Tissues For Accurate Gene Expression Normalization In Preclinical Studies
Biomarker Assay Development And Analysis Using LI-COR Systems For Multiplex Western Blotting In Tissue And Cell Lysates
20+
Years Of Biomarker Assay Services With Industry-Leading Turnaround
450+
Biomarker Assays Are Offered Using Commercial Kits Or De Novo Assays Tailored To Your Specific Needs
Partner with NorthEast BioLab for expert biomarker analysis in pharmacodynamics and drug discovery. Our team specializes in immunoassays, PCR, cell-based assays, and chromatography, with a proven track record in multiplexing and addressing matrix interference. We deliver biomarker services within 6-8 weeks, followed by an audited report and validation/qualification details. Our expertise ensures resource optimization, cost reduction, and timely progress.
We look forward to collaborating with you on your biomarker assay. Our team values transparency and works closely with you to understand your specific requirements. To prepare a detailed proposal and timeline for your project, we request the following information:
This information helps us provide an accurate and tailored proposal for your biomarker data analysis needs.
“NorthEast BioLab goes the extra mile. We look forward to more meaningful collaborations.”
NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms
“NorthEast BioLab is the most responsive and thorough bioanalysis lab services CRO.”
NorthEast BioLab’s scientists deliver high-quality data on time and within budget
NorthEast BioLab is a responsive, collaborative, and reliable partner
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data

Biomarker research, discovery, and qualification are pivotal in modern drug development from demonstrating proof-of-concept (POC) to establishing drug safety and …
20+ Years of Experience with swift and high-value biomarker services assay development, validation, and analysis for preclinical and clinical studies. Our expertise ensures the delivery of high-quality results tailored to your specific research needs.






We Judiciously Invest In Our People, Solutions And Infrastructure, And Regularly Review Our Business Processes And Practices To Exceed Sponsor Expectations
Answers To Additional Cytokine Analysis, Biomarker Assay Questions Popular Among Our Potential Clients.
Biomarkers are measurable indicators of biological processes, conditions, or diseases. They are essential for diagnosing diseases, monitoring disease progression, and assessing the effectiveness of treatments.
Biomarker testing and analysis involve using various methods to measure biomarkers in biological samples. This analysis helps identify specific biomarkers related to diseases, drug effects, or therapeutic outcomes.
We offer a wide range of biomarker testing services, including multiplex assays, pharmacodynamic biomarker assays, and gene expression analysis using advanced platforms like ELISA, MSD, Luminex, and LC-MS.
Our testing process includes sample collection, biomarker assay development, validation, and quantification using platforms such as qPCR, flow cytometry, and Western blot. We tailor each assay to the needs of the study, ensuring accurate and reliable results.
We utilize a variety of cutting-edge platforms for biomarker research, including ELISA, Luminex, MSD, qPCR, dPCR, and LC-MS. These technologies allow for highly sensitive and multiplexed analysis, ensuring comprehensive biomarker profiling.
Biomarker assays are crucial during drug development for target identification, dose optimization, patient stratification, and monitoring therapeutic efficacy. They provide essential biomarker data on how a drug interacts with its target and the biological system.
Our biomarker discovery services focus on identifying novel biomarkers through genomic, proteomic, and metabolomic profiling. These services support early-phase research and help identify potential biomarkers for disease diagnosis and therapeutic response.
We provide comprehensive biomarker development services, including assay design, optimization, and qualification. Our goal is to create robust, reproducible assays that can be used for clinical trials or therapeutic monitoring.
Our biomarker validation services ensure that biomarkers perform reliably in real-world scenarios. This includes testing biomarker specificity, sensitivity, and reproducibility across diverse sample types.
Biomarker qualification services ensure that a biomarker is fit for its intended use in clinical trials or as a diagnostic tool. This process includes evaluating assay performance, accuracy, and clinical relevance.
Biomarker testing accelerates drug development by providing insights into drug efficacy, safety profiles, and optimal patient populations. This leads to more informed decision-making, reducing risks and improving the chances of regulatory approval.